Turn promising hits
into proven leads.
We help you see how compounds engage their targets in real cells – so you can focus on molecules that truly work.
Primary Screen
Speed up your drug discovery process with efficient, high-throughput screening.
Hit Confirmation
Refine the compound design and prioritize the strongest candidates
Potency Ranking
Prioritize compounds to lower the risk of failures in later development stages.
Selectivity Profiling
Reveal off-target interactions missed by conventional panels with unbiased, proteome-wide profiling
Why CETSA?
What makes CETSA different?
See CETSA in action
Read our case stories.
Selectivity Profiling: Unbiased Analysis of Compound Selectivity in Drug Discovery
Join us for an in-depth webinar exploring how CETSA® Selectivity Profiling empowers smarter decision-making in drug discovery. Drew Nager will share how Pfizer Oncology leverages Pelago Bioscience’s C…
Novel Applications of the Cellular Thermal Shift Assay (CETSA) Provide New Insights for Drug Discovery
Join AbbVie scientists Shitalben Patel and Jami R. Erickson as they showcase their innovative advancements, transforming CETSA® into a high-throughput flow-based platform and introducing new whole blo…
Unbiased Selectivity Profiling: with CETSA® and Mass Spectrometry
Unbiased Selectivity Profiling: Revealing True Compound Specificity and Off-Target Interactions CETSA mass spectrometry profiling enables unbiased analysis of compound selectivity in drug discovery—he…